US Broker Ratings

Relay Therapeutics, Inc. (RLAY) Stock Analysis: Understanding the 79.58% Potential Upside

Relay Therapeutics, Inc. (NASDAQ: RLAY) is attracting attention within the biotechnology sector, not only for its innovative approach to drug discovery but also for its potential..

Cel-Sci Corporation (CVM) Stock Analysis: Unveiling a Biotechnology Giant with 672% Upside Potential

Cel-Sci Corporation (NASDAQ: CVM), a clinical-stage biotechnology company, stands at a pivotal point with its market cap at $43.96 million and a stock price currently at..

Treace Medical Concepts, Inc. (TMCI) Stock Analysis: Exploring a Promising 111% Upside Potential

For investors looking to capitalize on the burgeoning medical technology sector, Treace Medical Concepts, Inc. (NASDAQ: TMCI) presents a compelling opportunity. This U.S.-based company specializes in..

Avanos Medical, Inc. (AVNS) Stock Analysis: Insights into a Healthcare Device Innovator with Growth Potential

Avanos Medical, Inc. (NYSE: AVNS), headquartered in Alpharetta, Georgia, stands at the forefront of healthcare innovation, delivering a range of medical device solutions across North America..

Immatics N.V. (IMTX) Stock Analysis: A 95.92% Upside Opportunity in the Biotech Sector

Immatics N.V. (NASDAQ: IMTX), a biopharmaceutical firm specializing in innovative cancer treatments, is catching the eye of investors with a compelling potential upside of nearly 96%...

Community Health Systems, Inc. (CYH) Stock Analysis: Is a 21% Upside Worth the Risk?

Community Health Systems, Inc. (NYSE: CYH), a key player in the healthcare sector, is catching the eye of investors with its potential 21.34% upside. As a..

Atai Beckley N.V. (ATAI): Investor Outlook on a Biotech Innovator with 206% Upside Potential

Atai Beckley N.V. (NASDAQ: ATAI) is making waves in the biotechnology sector with its innovative approach to mental health treatment. Operating out of the Netherlands, this..

AngioDynamics, Inc. (ANGO): Investor Outlook Reveals 45% Upside Potential Amid Strong Buy Ratings

AngioDynamics, Inc. (NASDAQ: ANGO), a prominent player in the healthcare sector, is capturing investor attention with its medical technology innovations and promising market position. The company,..

Savara, Inc. (SVRA) Stock Analysis: A Promising Biotech with 70% Upside Potential

Savara, Inc. (SVRA), a clinical-stage biopharmaceutical company, has caught the attention of investors with its focus on rare respiratory diseases and a promising upside potential. With..

Maze Therapeutics, Inc. (MAZE) Stock Analysis: A Biotech Innovator with a 14.61% Potential Upside

Maze Therapeutics, Inc. (NASDAQ: MAZE) stands out in the biotechnology sector as a promising player in the development of precision medicines for renal, cardiovascular, and metabolic..

REGENXBIO Inc. (RGNX) Stock Analysis: Exploring a Potential 121% Upside in the Biotech Sector

REGENXBIO Inc. (NASDAQ: RGNX), a burgeoning player in the biotechnology sector, is gaining attention for its innovative gene therapies and a potential upside that could intrigue..

Altimmune, Inc. (ALT) Stock Analysis: Unpacking a Potential 253% Upside in Biotech

Altimmune, Inc. (NASDAQ: ALT), a clinical-stage biopharmaceutical company, is emerging as a compelling opportunity for investors in the healthcare sector. Specializing in treatments for obesity, metabolic,..

Phibro Animal Health Corporation (PAHC): Investor Outlook Focused on Growth Potential and Robust Revenue Expansion

Phibro Animal Health Corporation (NASDAQ: PAHC) presents a compelling opportunity for investors with its solid presence in the healthcare sector, specifically within the specialty and generic..

Mind Medicine (MNMD) Stock Analysis: A Biotech Prospect with Over 100% Potential Upside

Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), a prominent player in the healthcare sector, specifically within biotechnology, has captured investor attention recently with its compelling growth narrative...

Tyra Biosciences, Inc. (TYRA) Stock Analysis: A Promising 43.54% Upside Potential in Biotech Innovation

Tyra Biosciences, Inc. (NASDAQ: TYRA), a burgeoning player in the biotechnology sector, is catching the attention of investors with its promising pipeline and an impressive potential..

Fortrea Holdings Inc. (FTRE)

⚠️ No article content returned.

..

Autolus Therapeutics (AUTL) Stock Analysis: Exploring the 506% Potential Upside

Autolus Therapeutics plc (NASDAQ: AUTL), a UK-based biotechnology firm, has captured the attention of investors with its ambitious pursuit of cutting-edge T cell therapies for cancer..

Arvinas, Inc. (ARVN): Investor Outlook on a Biotech Innovator with a 10.26% Potential Upside

Arvinas, Inc. (NASDAQ: ARVN), a pioneering biotechnology firm in the healthcare sector, is attracting attention with its innovative approach to drug development and a notable potential..

Zenas BioPharma, Inc. (ZBIO) Stock Analysis: A Promising Biotech with 36% Potential Upside

Zenas BioPharma, Inc. (NASDAQ: ZBIO), a clinical-stage biopharmaceutical company specializing in immunology-based therapies, stands out in the biotechnology sector with a market capitalization of $1.88 billion...

Orthofix Medical Inc. (OFIX) Stock Analysis: Exploring a Potential 46.53% Upside for Investors

Orthofix Medical Inc. (NASDAQ: OFIX) stands out in the healthcare sector, particularly in the medical devices industry. With a market capitalization of $616.17 million, this U.S.-based..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds